Adrian Hepner - Net Worth and Insider Trading
Adrian Hepner Net Worth
The estimated net worth of Adrian Hepner is at least $65,200 dollars as of 2024-12-02. Adrian Hepner is the Chief Medical Officer of Coya Therapeutics Inc and owns about 10,000 shares of Coya Therapeutics Inc (COYA) stock worth over $65,200. Details can be seen in Adrian Hepner's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Adrian Hepner has not made any transactions after 2023-01-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Adrian Hepner
Adrian Hepner Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Adrian Hepner owns 2 companies in total, including Eagle Pharmaceuticals Inc (EGRX) , and Coya Therapeutics Inc (COYA) .
Click here to see the complete history of Adrian Hepner’s form 4 insider trades.
Insider Ownership Summary of Adrian Hepner
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| EGRX | Eagle Pharmaceuticals Inc | 2015-03-13 | Executive VP |
| COYA | Coya Therapeutics Inc | 2023-01-03 | Chief Medical Officer |
Adrian Hepner Latest Holdings Summary
Adrian Hepner currently owns a total of 1 stock. Adrian Hepner owns 10,000 shares of Coya Therapeutics Inc (COYA) as of January 3, 2023, with a value of $65,200.
Latest Holdings of Adrian Hepner
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| COYA | Coya Therapeutics Inc | 2023-01-03 | 10,000 | 6.52 | 65,200 |
Holding Weightings of Adrian Hepner
Adrian Hepner Form 4 Trading Tracker
According to the SEC Form 4 filings, Adrian Hepner has made a total of 1 transactions in Coya Therapeutics Inc (COYA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Coya Therapeutics Inc is the acquisition of 10,000 shares on January 3, 2023, which cost Adrian Hepner around $46,500.
Insider Trading History of Adrian Hepner
- 1
Adrian Hepner Trading Performance
GuruFocus tracks the stock performance after each of Adrian Hepner's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Adrian Hepner is -12.9%. GuruFocus also compares Adrian Hepner's trading performance to market benchmark return within the same time period. The performance of stocks bought by Adrian Hepner within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Adrian Hepner's insider trading performs compared to the benchmark.
Performance of Adrian Hepner
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -14.19 | | | | | |
| Relative Return to S&P 500(%) | -22.36 | | | | | |
Adrian Hepner Ownership Network
Adrian Hepner Owned Company Details
What does Eagle Pharmaceuticals Inc do?
Who are the key executives at Eagle Pharmaceuticals Inc?
Adrian Hepner is the Executive VP of Eagle Pharmaceuticals Inc. Other key executives at Eagle Pharmaceuticals Inc include director & President and CEO Scott Tarriff , EVP & Chief Commercial Officer Michael Shawn Moran , and Chief Medical Officer Judith Ng-cashin .
Eagle Pharmaceuticals Inc (EGRX) Insider Trades Summary
Over the past 18 months, Adrian Hepner made no insider transaction in Eagle Pharmaceuticals Inc (EGRX). Other recent insider transactions involving Eagle Pharmaceuticals Inc (EGRX) include a net sale of 41,864 shares made by Scott Tarriff ,
In summary, during the past 3 months, insiders sold 0 shares of Eagle Pharmaceuticals Inc (EGRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 41,864 shares of Eagle Pharmaceuticals Inc (EGRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 41,864 shares.
Eagle Pharmaceuticals Inc (EGRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eagle Pharmaceuticals Inc Insider Transactions
Adrian Hepner Mailing Address
Above is the net worth, insider trading, and ownership report for Adrian Hepner. You might contact Adrian Hepner via mailing address: C/o Coya Therapeutics, Inc., 5850 San Felipe St., Suite 500, Houston Tx 77057.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
